PL3190106T3 - Polieterowe analogi desferitiocyny - Google Patents

Polieterowe analogi desferitiocyny

Info

Publication number: PL3190106T3
Authority: PL; Poland
Prior art keywords: polyether analogues; desferrithiocin polyether; desferrithiocin; analogues; polyether
Prior art date: 2005-04-04

Application number

PL16196408T

Other languages

English (en)

Inventor

Raymond J Bergeron

Original Assignee

Univ Florida

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-04-04

Filing date

2006-03-22

Publication date

2019-10-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36676582&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3190106(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-03-22 Application filed by Univ Florida filed Critical Univ Florida

2019-10-31 Publication of PL3190106T3 publication Critical patent/PL3190106T3/pl

Links

239000004721 Polyphenylene oxide Substances 0.000 title 1
MJWAGSZZOQMRNY-SNVBAGLBSA-N chembl11301 Chemical compound OC(=O)[C@@]1(C)CSC(C=2C(=CC=CN=2)O)=N1 MJWAGSZZOQMRNY-SNVBAGLBSA-N 0.000 title 1
229920000570 polyether Polymers 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/04—Chelating agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/10—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Hematology (AREA)
Diabetes (AREA)
Toxicology (AREA)
Biochemistry (AREA)
Obesity (AREA)
Gastroenterology & Hepatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Saccharide Compounds (AREA)

PL16196408T 2005-04-04 2006-03-22 Polieterowe analogi desferitiocyny PL3190106T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US66804505P	2005-04-04	2005-04-04
PCT/US2006/010945 WO2006107626A1 (en)	2005-04-04	2006-03-22	Desferrithiocin polyether analogues
EP16196408.5A EP3190106B1 (en)	2005-04-04	2006-03-22	Desferrithiocin polyether analogues
EP06739627.5A EP1866296B1 (en)	2005-04-04	2006-03-22	Desferrithiocin polyether analogues

Publications (1)

Publication Number	Publication Date
PL3190106T3 true PL3190106T3 (pl)	2019-10-31

Family

ID=36676582

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL06739627T PL1866296T3 (pl)	2005-04-04	2006-03-22	Polieterowe analogi desferritiocyny
PL16196408T PL3190106T3 (pl)	2005-04-04	2006-03-22	Polieterowe analogi desferitiocyny

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PL06739627T PL1866296T3 (pl)	2005-04-04	2006-03-22	Polieterowe analogi desferritiocyny

Country Status (14)

Country	Link
US (6)	US8278458B2 (pl)
EP (2)	EP1866296B1 (pl)
JP (3)	JP5202299B2 (pl)
CN (1)	CN101189216B (pl)
AU (1)	AU2006232929B9 (pl)
BR (1)	BRPI0610644B8 (pl)
CA (1)	CA2603385C (pl)
CY (1)	CY1119002T1 (pl)
DK (2)	DK1866296T3 (pl)
ES (2)	ES2732625T3 (pl)
MX (1)	MX2007012226A (pl)
PL (2)	PL1866296T3 (pl)
TR (1)	TR201910900T4 (pl)
WO (1)	WO2006107626A1 (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6083966A (en)	1998-08-31	2000-07-04	University Of Florida	Thiazoline acid derivatives
WO2005034949A1 (en)	2003-09-09	2005-04-21	University Of Florida	Desferrithiocin derivatives and their use as iron chelators
PL1866296T3 (pl)	2005-04-04	2017-05-31	University Of Florida Research Foundation, Inc.	Polieterowe analogi desferritiocyny
CA2684837A1 (en) *	2006-12-12	2008-10-30	Raymond J. Bergeron, Jr.	Desferrithiocin analogue actinide decorporation agents
US8324397B2 (en) *	2007-03-15	2012-12-04	University Of Florida Research Foundation, Inc.	Desferrithiocin polyether analogues
NZ605452A (en)	2008-07-14	2014-05-30	Ferrokin Biosciences Inc	Novel salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents
BR112012001761A2 (pt) *	2009-07-27	2017-05-09	Ferrokin Bioscience Inc	composto de formula i, composto farmacêutica e método de tratamento de uma condição mediada por metal em um indivduo
WO2011028255A2 (en) *	2009-08-25	2011-03-10	University Of Florida Research Foundation, Inc.	Desferrithiocin polyether analogues and uses thereof
US9045440B2 (en)	2010-05-04	2015-06-02	Ferrokin Biosciences, Inc.	Desazadesferrothiocin and desazadesferrothiocin polyether analogues as metal chelation agents
CA2857990A1 (en)	2011-12-09	2013-06-13	Ferrokin Biosciences, Inc.	Oral formulations for treating metal overload
US20140343110A1 (en)	2011-12-16	2014-11-20	University Of Florida Research Foundation, Inc.	Uses of 4'-desferrithiocin analogs
EP2970162A1 (en)	2013-03-15	2016-01-20	Ferrokin Biosciences, Inc.	Polymorph forms of desazadesferrithiocin analogs
AU2014352780A1 (en) *	2013-11-22	2016-06-09	University Of Florida Research Foundation, Inc.	Desferrithiocin analogs and uses thereof
JP2017526815A (ja) *	2014-07-18	2017-09-14	アプライドマテリアルズインコーポレイテッドＡｐｐｌｉｅｄＭａｔｅｒｉａｌｓ，Ｉｎｃｏｒｐｏｒａｔｅｄ	レーザ及びプラズマを用いた付加製造
WO2016176343A1 (en)	2015-04-27	2016-11-03	University Of Florida Research Foundation, Incorporated	Metabolically programmed metal chelators and uses thereof
US10982136B2 (en)	2016-02-26	2021-04-20	The Regents Of The University Of California	Ligand-sensitized lanthanide nanocrystals as ultraviolet downconverters
JP7125396B2 (ja)	2016-08-05	2022-08-24	アブフェロファーマシューティカルズ，インコーポレイテッド	金属誘発性疾患を治療するための投与レジメン
US11235076B2 (en)	2016-08-29	2022-02-01	Fred Hutchinson Cancer Research Center	Chelating platform for delivery of radionuclides
CA3035966A1 (en)	2016-09-06	2018-03-15	The Regents Of The University Of California	Formulations of hydroxypyridonate actinide/lanthanide decorporation agents
WO2018097871A2 (en)	2016-09-29	2018-05-31	The Regents Of The University Of California	Separation of metal ions by liquid-liquid extraction
US12479792B2 (en)	2016-09-29	2025-11-25	The Regents Of The University Of California	Compositions of chelating molecules

Family Cites Families (94)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3274207A (en)		1966-09-20		Processes for preparing thiazole carboxylic acids
US3809754A (en)	1968-12-31	1974-05-07	Medial De Toledo & Cie	Method of treating diseases of the mucous membrane using compounds of a thiazolidine carboxylic acid and pharmaceutical preparations thereof
US3882110A (en)	1969-06-11	1975-05-06	Roussel Uclaf	Novel 2-alkyl-5-thiazole-carboxylic acid derivatives
IT1050117B (it)	1969-09-17	1981-03-10	Godo Shusei Kk	Metodo per la sintesi dell acido aeruginoico
FR2062120A5 (pl)	1969-10-10	1971-06-25	Messier Fa
FR2141526B1 (pl)	1971-06-14	1975-05-30	Roussel Uclaf
DE2245560A1 (de)	1972-09-16	1974-03-21	Basf Ag	Verfahren zur herstellung von 4alkoxycarbonyl-2-thiazolinen
AU528115B2 (en)	1978-04-08	1983-04-14	Santen Pharmaceutical Co. Ltd.	Antihypertensive 4-thiazolidine/carboxylic acids
CS205217B1 (cs)	1979-04-05	1981-05-29	Zdenek Vitamvas	Dozimetr ionizujícího záření
US4270537A (en)	1979-11-19	1981-06-02	Romaine Richard A	Automatic hypodermic syringe
DE3002989A1 (de)	1980-01-29	1981-07-30	Hoechst Ag, 6000 Frankfurt	Hydroxyphenyl-thiazol, -thiazolin und -thiazolidin-carbonsaeuren, verfahren zu ihrer herstellung und ihre verwendung zur beeinflussung des kollagenstoffwechsels
DE3170401D1 (en)	1980-07-28	1985-06-13	Ciba Geigy Ag	Triazoline derivatives and processes for their preparation
JPS5758682A (en)	1980-07-28	1982-04-08	Ciba Geigy Ag	Thiazoline derivatives, manufacture and medicinal composition containing same
JPS5772975A (en)	1980-10-24	1982-05-07	Kureha Chem Ind Co Ltd	2-substituted phenylthiazole derviative, and medicine for peptic ulcer containing said derivative as active component
US4367233A (en)	1981-10-02	1983-01-04	American Home Products Corporation	Inhibitors of mammalian collagenase
DE3586683T2 (de)	1984-12-18	1993-04-08	Clark Pharma Dev	Antitumorzusammensetzungen enthaltend ein reaktionsprodukt zwischen einem cytotoxischen aldehyd und penicillamin und deren verwendung zur herstellung von arzneimitteln.
US4596556A (en)	1985-03-25	1986-06-24	Bioject, Inc.	Hypodermic injection apparatus
HU200177B (en)	1985-06-18	1990-04-28	Biogal Gyogyszergyar	Process for producing thiazolidinecarboxylic acids and pharmaceutical compositions comprising such compounds
US4736060A (en)	1985-08-06	1988-04-05	Nippon Rikagakuyakuhin Co., Ltd.	Method for optical resolution of DL-cysteine and (R,S)-1-(1-naphthyl) ethylamine
EP0214101A3 (de)	1985-09-03	1989-05-31	Ciba-Geigy Ag	Verwendung von Eisen(III)-Chelatoren vom Typ Desferrioxamin B und Desferriferrithiocin zur Behandlung von Malaria
EP0214933A3 (de)	1985-09-03	1989-05-24	Ciba-Geigy Ag	Kombinationspräparate zur Behandlung von Malaria
JPS62142168A (ja)	1985-10-16	1987-06-25	Mitsubishi Chem Ind Ltd	チアゾ−ル誘導体及びそれを有効成分とするロイコトリエンきつ抗剤
DE3621540A1 (de)	1986-06-27	1988-01-07	Basf Ag	Chinolinderivate, verfahren zu ihrer herstellung, diese enthaltende mikrobizide und ihre verwendung zur bekaempfung von bakterien und pilzen
CA1283827C (en)	1986-12-18	1991-05-07	Giorgio Cirelli	Appliance for injection of liquid formulations
GB8704027D0 (en)	1987-02-20	1987-03-25	Owen Mumford Ltd	Syringe needle combination
US4941880A (en)	1987-06-19	1990-07-17	Bioject, Inc.	Pre-filled ampule and non-invasive hypodermic injection device assembly
US4940460A (en)	1987-06-19	1990-07-10	Bioject, Inc.	Patient-fillable and non-invasive hypodermic injection device assembly
US4790824A (en)	1987-06-19	1988-12-13	Bioject, Inc.	Non-invasive hypodermic injection device
DE3735757A1 (de)	1987-10-22	1989-05-03	Degussa	Optisch aktive salze aus einem substituierten thiazolidin-4-carboxylat und 3-chlor-2-hydroxypropyltrimethylammonium, deren herstellung und verwendung
EP0325559B1 (de)	1988-01-20	1993-12-15	Ciba-Geigy Ag	Verfahren zur Herstellung von Komplexverbindungen
US5339163A (en)	1988-03-16	1994-08-16	Canon Kabushiki Kaisha	Automatic exposure control device using plural image plane detection areas
FR2638359A1 (fr)	1988-11-03	1990-05-04	Tino Dalto	Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
US5182402A (en)	1988-11-07	1993-01-26	Imperial Chemical Industries Plc	Herbicidal compositions
GB8826035D0 (en)	1988-11-07	1988-12-14	Ici Plc	Herbicidal compositions
US5106992A (en)	1989-07-28	1992-04-21	E. R. Squibb & Sons, Inc.	3,5-dihydroxypentanoic acid derivatives useful as antihypercholesterolemic agents and method for preparing same
US5064413A (en)	1989-11-09	1991-11-12	Bioject, Inc.	Needleless hypodermic injection device
US5312335A (en)	1989-11-09	1994-05-17	Bioject Inc.	Needleless hypodermic injection device
US5190521A (en)	1990-08-22	1993-03-02	Tecnol Medical Products, Inc.	Apparatus and method for raising a skin wheal and anesthetizing skin
NL9001955A (nl)	1990-09-05	1992-04-01	Cedona Pharm Bv	Nieuwe thiazolidinederivaten.
US5393777A (en)	1990-11-15	1995-02-28	State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon Health Sciences University	Deferration using anguibactin siderophore
CA2073981C (en)	1990-11-30	2002-01-08	Shiro Kondo	2-arylthiazole derivatives and pharmaceutical composition thereof
DK0513387T3 (da)	1990-11-30	2000-06-05	Otsuka Pharma Co Ltd	Thiazolderivater som inhibitorer af aktivt oxygen
US5527288A (en)	1990-12-13	1996-06-18	Elan Medical Technologies Limited	Intradermal drug delivery device and method for intradermal delivery of drugs
FR2677021B1 (fr)	1991-05-31	1993-10-01	Upsa Laboratoires	Nouveaux derives de thiazole antagonistes des recepteurs a l'angiotensine ii; leurs procedes de preparation, compositions pharmaceutiques les contenant.
GB9118204D0 (en)	1991-08-23	1991-10-09	Weston Terence E	Needle-less injector
SE9102652D0 (sv)	1991-09-13	1991-09-13	Kabi Pharmacia Ab	Injection needle arrangement
US5328483A (en)	1992-02-27	1994-07-12	Jacoby Richard M	Intradermal injection device with medication and needle guard
US5383851A (en)	1992-07-24	1995-01-24	Bioject Inc.	Needleless hypodermic injection device
US5569189A (en)	1992-09-28	1996-10-29	Equidyne Systems, Inc.	hypodermic jet injector
US5334144A (en)	1992-10-30	1994-08-02	Becton, Dickinson And Company	Single use disposable needleless injector
WO1994011367A1 (en)	1992-11-16	1994-05-26	University Of Florida Research Foundation Inc.	2-(pyrid-2'-yl)-2-thiazoline-4(s)-carboxylic acid derivatives
US5840739A (en)	1992-11-16	1998-11-24	University Of Florida Research Foundation, Inc.	Thiazoline acid derivatives
DE4301356A1 (de)	1993-01-20	1994-07-21	Basf Ag	Verfahren zur Herstellung von 2-Alkyl-4-fluormethyl-thiazolcarbonsäure-alkylestern
WO1995024176A1 (en)	1994-03-07	1995-09-14	Bioject, Inc.	Ampule filling device
US5466220A (en)	1994-03-08	1995-11-14	Bioject, Inc.	Drug vial mixing and transfer device
US5599302A (en)	1995-01-09	1997-02-04	Medi-Ject Corporation	Medical injection system and method, gas spring thereof and launching device using gas spring
US5730723A (en)	1995-10-10	1998-03-24	Visionary Medical Products Corporation, Inc.	Gas pressured needle-less injection device and method
US5893397A (en)	1996-01-12	1999-04-13	Bioject Inc.	Medication vial/syringe liquid-transfer apparatus
GB9607549D0 (en)	1996-04-11	1996-06-12	Weston Medical Ltd	Spring-powered dispensing device
FR2749583B1 (fr)	1996-06-07	1998-08-21	Lipha	Nouveaux derives de thiazolidine -2,4- dione substitues, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
US20020049316A1 (en)	1997-04-29	2002-04-25	Halbert Stacie Marie	Protease inhibitors
US5993412A (en)	1997-05-19	1999-11-30	Bioject, Inc.	Injection apparatus
US6373912B1 (en)	1997-06-16	2002-04-16	Legerity, Inc.	Phase-locked loop arrangement with fast lock mode
IT1298087B1 (it)	1998-01-08	1999-12-20	Fiderm S R L	Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
ATE285232T1 (de) *	1998-02-04	2005-01-15	Univ Florida	N,n'-bis(2-hydroxybenzyl)ethylendiamin-n,n'- diessigsäure und natriumsalze davon zur eisenchelatierungstherapie
MA26618A1 (fr)	1998-04-09	2004-12-20	Smithkline Beecham Corp	Composes et compositions pharmaceutiques pour le traitement du paludisme
US6147070A (en)	1998-06-05	2000-11-14	Facchini; Francesco	Methods and compositions for controlling iron stores to treat and cure disease states
US6083966A (en)	1998-08-31	2000-07-04	University Of Florida	Thiazoline acid derivatives
US6159983A (en)	1998-09-18	2000-12-12	University Of Florida	Method and composition for treatment of inflammatory bowel disease
EP1143951A3 (en)	1998-09-21	2002-02-06	University Of Florida Research Foundation, Inc.	Antimalarial agents
US6251927B1 (en)	1999-04-20	2001-06-26	Medinox, Inc.	Methods for treatment of sickle cell anemia
DE19948434A1 (de)	1999-10-08	2001-06-07	Gruenenthal Gmbh	Substanzbibliothek enthaltend bicyclische Imidazo-5-amine und/oder bicyclische Imidazo-3-amine
US7160855B2 (en)	2002-03-14	2007-01-09	Children's Hospital & Research Center At Oakland	Enhancement of iron chelation therapy
US20040044220A1 (en)	2002-08-22	2004-03-04	University Of Florida	Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin
US20040132789A1 (en)	2002-08-22	2004-07-08	University Of Florida	Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin
JP2007505044A (ja)	2003-09-09	2007-03-08	ユニバーシティオブフロリダリサーチファウンデイション、インコーポレイテッド	ポリアミン−金属キレーター接合体
WO2005034949A1 (en)	2003-09-09	2005-04-21	University Of Florida	Desferrithiocin derivatives and their use as iron chelators
EP1819334A1 (en)	2004-11-19	2007-08-22	Shiva Biomedical, LLC	Methods of treating erythropoietin-resistance
PL1866296T3 (pl)	2005-04-04	2017-05-31	University Of Florida Research Foundation, Inc.	Polieterowe analogi desferritiocyny
US20080194518A1 (en)	2005-12-23	2008-08-14	MOOKERJEE Pradip	Antimicrobial Compositions
CN101129381B (zh)	2006-08-25	2012-02-01	天津和美生物技术有限公司	含β-内酰胺类抗生素和离子螯合剂的抗生素复方
CA2684837A1 (en) *	2006-12-12	2008-10-30	Raymond J. Bergeron, Jr.	Desferrithiocin analogue actinide decorporation agents
US8324397B2 (en) *	2007-03-15	2012-12-04	University Of Florida Research Foundation, Inc.	Desferrithiocin polyether analogues
FR2922210A1 (fr)	2007-10-11	2009-04-17	Univ Louis Pasteur Etablisseme	Nouveaux composes, preparation et utilisations
NZ605452A (en)	2008-07-14	2014-05-30	Ferrokin Biosciences Inc	Novel salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents
PL385765A1 (pl)	2008-07-28	2010-02-01	Maciej Żurek	Sposób sterowania łopatą napędową względem kierunku wiatru, zwłaszcza w silniku wiatrowym i wodnym o osi prostopadłej do kierunku wiatru oraz silnik wiatrowy o osi prostopadłej do kierunku wiatru z łopatą napędową sterowaną względem kierunku wiatru
BR112012001761A2 (pt)	2009-07-27	2017-05-09	Ferrokin Bioscience Inc	composto de formula i, composto farmacêutica e método de tratamento de uma condição mediada por metal em um indivduo
WO2011028255A2 (en)	2009-08-25	2011-03-10	University Of Florida Research Foundation, Inc.	Desferrithiocin polyether analogues and uses thereof
US9045440B2 (en)	2010-05-04	2015-06-02	Ferrokin Biosciences, Inc.	Desazadesferrothiocin and desazadesferrothiocin polyether analogues as metal chelation agents
WO2012027794A2 (en)	2010-09-01	2012-03-08	The Mental Health Research Institute Of Victoria	Method of treatment and agents useful for same
US20140343110A1 (en)	2011-12-16	2014-11-20	University Of Florida Research Foundation, Inc.	Uses of 4'-desferrithiocin analogs
US20140323534A1 (en)	2011-12-16	2014-10-30	University Of Florida Research Foundation, Inc.	Uses of 3'-desferrithiocin analogs
WO2014134701A1 (en)	2013-03-07	2014-09-12	Kane Biotech Inc.	Antimicrobial-antibiofilm compositions and methods of use thereof
AU2014352780A1 (en)	2013-11-22	2016-06-09	University Of Florida Research Foundation, Inc.	Desferrithiocin analogs and uses thereof

2006
- 2006-03-22 PL PL06739627T patent/PL1866296T3/pl unknown
- 2006-03-22 EP EP06739627.5A patent/EP1866296B1/en not_active Expired - Lifetime
- 2006-03-22 BR BRPI0610644A patent/BRPI0610644B8/pt not_active IP Right Cessation
- 2006-03-22 DK DK06739627.5T patent/DK1866296T3/en active
- 2006-03-22 CA CA2603385A patent/CA2603385C/en not_active Expired - Fee Related
- 2006-03-22 ES ES16196408T patent/ES2732625T3/es not_active Expired - Lifetime
- 2006-03-22 WO PCT/US2006/010945 patent/WO2006107626A1/en not_active Ceased
- 2006-03-22 MX MX2007012226A patent/MX2007012226A/es active IP Right Grant
- 2006-03-22 DK DK16196408.5T patent/DK3190106T3/da active
- 2006-03-22 PL PL16196408T patent/PL3190106T3/pl unknown
- 2006-03-22 CN CN2006800198675A patent/CN101189216B/zh not_active Expired - Fee Related
- 2006-03-22 AU AU2006232929A patent/AU2006232929B9/en not_active Ceased
- 2006-03-22 EP EP16196408.5A patent/EP3190106B1/en not_active Expired - Lifetime
- 2006-03-22 ES ES06739627.5T patent/ES2614086T3/es not_active Expired - Lifetime
- 2006-03-22 JP JP2008505360A patent/JP5202299B2/ja not_active Expired - Fee Related
- 2006-03-22 TR TR2019/10900T patent/TR201910900T4/tr unknown
2007
- 2007-10-04 US US11/973,001 patent/US8278458B2/en active Active
2012
- 2012-02-28 JP JP2012041370A patent/JP5771546B2/ja not_active Expired - Fee Related
- 2012-09-28 US US13/631,025 patent/US8722899B2/en not_active Expired - Fee Related
2014
- 2014-04-29 US US14/264,959 patent/US9096553B2/en not_active Expired - Lifetime
2015
- 2015-04-06 JP JP2015077336A patent/JP6178816B2/ja not_active Expired - Fee Related
- 2015-07-28 US US14/811,598 patent/US9567309B2/en not_active Expired - Fee Related
2017
- 2017-01-31 CY CY20171100135T patent/CY1119002T1/el unknown
- 2017-02-09 US US15/428,232 patent/US9994535B2/en not_active Expired - Fee Related
2018
- 2018-06-11 US US16/005,483 patent/US20180290990A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20130030028A1 (en)	2013-01-31
ES2614086T3 (es)	2017-05-29
DK3190106T3 (da)	2019-07-15
AU2006232929B2 (en)	2009-11-05
JP5202299B2 (ja)	2013-06-05
WO2006107626A1 (en)	2006-10-12
US20150336911A1 (en)	2015-11-26
TR201910900T4 (tr)	2019-08-21
DK1866296T3 (en)	2017-02-13
US20080214630A1 (en)	2008-09-04
CA2603385C (en)	2014-07-15
EP1866296B1 (en)	2016-11-02
AU2006232929A1 (en)	2006-10-12
JP6178816B2 (ja)	2017-08-09
JP2012131814A (ja)	2012-07-12
EP3190106A1 (en)	2017-07-12
JP2008536833A (ja)	2008-09-11
PL1866296T3 (pl)	2017-05-31
JP2015145403A (ja)	2015-08-13
BRPI0610644A2 (pt)	2010-07-13
US9567309B2 (en)	2017-02-14
EP3190106B1 (en)	2019-05-08
US8278458B2 (en)	2012-10-02
MX2007012226A (es)	2007-12-10
CN101189216B (zh)	2011-10-19
JP5771546B2 (ja)	2015-09-02
EP1866296A1 (en)	2007-12-19
ES2732625T3 (es)	2019-11-25
US20140235680A1 (en)	2014-08-21
US20170217912A1 (en)	2017-08-03
US8722899B2 (en)	2014-05-13
US9096553B2 (en)	2015-08-04
US20180290990A1 (en)	2018-10-11
CY1119002T1 (el)	2018-01-10
AU2006232929B9 (en)	2009-12-17
CA2603385A1 (en)	2006-10-12
BRPI0610644B1 (pt)	2020-09-29
BRPI0610644B8 (pt)	2021-05-25
CN101189216A (zh)	2008-05-28
US9994535B2 (en)	2018-06-12

Publication	Publication Date	Title
IL238492A0 (en)	2015-06-30	Desprethiocin polyether analogues
PL1866296T3 (pl)	2017-05-31	Polieterowe analogi desferritiocyny
PL2001468T3 (pl)	2013-03-29	Analogi tiazolidynodionu
IL209963A0 (en)	2011-02-28	Epitope analogues
IL187919A0 (en)	2008-03-20	4c
DE502006001600D1 (en)	2008-10-30	Pyrazolylcarboxanilide
PL2001469T3 (pl)	2012-10-31	Analogi tiazolidynodionu
ZA200803483B (en)	2009-02-25	Conveyor
GB0509371D0 (en)	2005-06-15	Resuscitators
GB2429679B (en)	2008-03-12	Jigsaw
EP1841430A4 (en)	2009-07-29	SUBSTITUTED PYRIDAZINYL AND PYRIMIDINYL-CHINOLIN-4-YLAMINE ANALOGUE
AU303882S (en)	2005-11-07	Jigsaw
EP1824490A4 (en)	2008-06-04	PIPERAZINYL-PYRIDINE ANALOGS
EP1806239A4 (en)	2009-11-25	the eraser
AU304291S (en)	2005-11-18	Jigsaw
GB0510594D0 (en)	2005-06-29	Resuscitators
GB0505116D0 (en)	2005-04-20	Level
GB0404183D0 (en)	2004-03-31	Resveratrol analogues
GB0510038D0 (en)	2005-06-22	Straightedge level
AU3239P (en)	2007-02-05	Balaroyal Nemesia foetans
GB0410325D0 (en)	2004-06-09	Improved ruler
AU3621P (en)	2008-09-23	Scacover Scaevola aemula
AU3685P (en)	2009-01-07	DOW10 Tristaniopsis laurina
GB0502736D0 (en)	2005-03-16	Demopod (studiopod)
GB0522528D0 (en)	2005-12-14	PPJS (peeJays) promotional-paperweigh-jambs